West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
The most recent EPS for West Pharmaceutical Services Inc is $2.04, beating expectations of $1.85.
How did West Pharmaceutical Services Inc WST's revenue perform in the last quarter?
West Pharmaceutical Services Inc revenue for the last quarter is $2.04
What is the revenue estimate for West Pharmaceutical Services Inc?
According to 14 of Wall street analyst, the revenue estimate of West Pharmaceutical Services Inc range from $868.35M to $793.41M
What's the earning quality score for West Pharmaceutical Services Inc?
West Pharmaceutical Services Inc has a earning quality score of B+/53.190754. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does West Pharmaceutical Services Inc report earnings?
West Pharmaceutical Services Inc next earnings report is expected in 2026-05-13
What are West Pharmaceutical Services Inc's expected earnings?
West Pharmaceutical Services Inc expected earnings is $802.32M, according to wall-street analysts.
Did West Pharmaceutical Services Inc beat earnings expectations?
West Pharmaceutical Services Inc recent earnings of $805.0M beat expectations.